Skip to main content
OpenTrials

Clinical trial condition

Chronic Lymphocytic Leukemia

Explore clinical trials studying Chronic Lymphocytic Leukemia. Study availability and eligibility vary by location and protocol.

528 public trials 91 recruiting studies
Refine in advanced search Browse all conditions

Chronic Lymphocytic Leukemia trial results

Completed

A Study of Ibrutinib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

NCT01611090

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +16 more
Locations
  • Birmingham, Alabama, United States
  • Phoenix, Arizona, United States
  • Berkeley, California, United States
  • Duarte, California, United States
View all 155 locations
View Trial Details
Completed

Vorinostat, Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

NCT00918723

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +22 more
Locations
  • Swedish Cancer Institute-Breast Center at First Hill Campus Seattle, Washington, United States
  • Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
View Trial Details
Completed

Fludarabine or Observation in Treating Patients With Stage 0, Stage I, or Stage II Chronic Lymphocytic Leukemia

NCT00262782

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations
  • Allg. Krankenhaus der Stadt Wien Universitaets-Kinderklinik Vienna, Austria
  • Hanuschkrankenhaus Vienna, Austria
  • Klinikum St. Marien Amberg, Germany
  • Internistische Praxis - Arnstadt Arnstadt, Germany
View all 117 locations
View Trial Details
Completed

A Study of Obinutuzumab + Bendamustine (BG) in Participants With Previously Untreated Chronic Lymphocytic Leukemia (CLL)

NCT02320487

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations
  • Clearview Cancer Institute Huntsville, Alabama, United States
  • Southern Cancer Center - Mobile Mobile, Alabama, United States
  • Ironwood Cancer TX & Rsch Ctrs Chandler, Arizona, United States
  • Arizona Oncology Associates, PC - HAL Tempe, Arizona, United States
View all 26 locations
View Trial Details
Completed

A Study Evaluating the Efficacy of Obinutuzumab and Bendamustine Treatment in Participants With Refractory or Relapsed Chronic Lymphocytic Leukemia

NCT02071225

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations
  • Hospital De Txagorritxu; Servicio de Hematologia Vitoria-Gasteiz, Alava, Spain
  • Hospital General Universitario de Elche; Servicio de Hematologia Elche, Alicante, Spain
  • Hospital Universitari Germans Trias i Pujol; Servicio de Hematologia Badalona, Barcelona, Spain
  • Hospital Mutua de Terrassa; Servicio de Hematologia Terrassa, Barcelona, Spain
View all 21 locations
View Trial Details
Completed

Pentostatin and Lymphocyte Infusion in Preventing Graft Rejection in Patients Who Have Undergone Donor Stem Cell Transplant

NCT00096161

Conditions
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Blood Protein Disorders, +42 more
Locations
  • Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States
  • LDS Hospital Salt Lake City, Utah, United States
  • VA Puget Sound Health Care System Seattle, Washington, United States
  • Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
View Trial Details
Completed

Rituximab Versus Observation as Maintenance Therapy in Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)

NCT01118234

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations
  • Landesklinikum Krems, Hämato-onkologisches Service Krems, Lower Austria, Austria
  • A.ö. Bezirkskrankenhaus Hall in Tirol, Innere Medizin / Hämato - Onkologie Hall in Tirol, Tyrol, Austria
  • Universitätsklinik Innsbruck, Innere MEdizin IV / Hämato-Onkologie Innsbruck, Tyrol, Austria
  • A.ö. Bezirkskrankenhaus Kufstein, Innere Medizin / Hämatologie / Onkologie Kufstein, Tyrol, Austria
View all 22 locations
View Trial Details
Completed

Donor Atorvastatin Treatment in Preventing Severe Acute GVHD After Nonmyeloablative Peripheral Blood Stem Cell Transplant in Patients With Hematological Malignancies

NCT01527045

Conditions
Aggressive Non-Hodgkin Lymphoma, Blasts Under 5 Percent of Bone Marrow Nucleated Cells, Blood Protein Disorders, +57 more
Locations
  • Presbyterian - Saint Lukes Medical Center - Health One Denver, Colorado, United States
  • Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
View Trial Details

Related conditions